nVerses Capital’s Avita Medical RCEL Stock Holding History
Bought
Maintained
Sold
Other funds holding RCEL
nVerses Capital's RCEL Position: Q3 2026 in Review
nVerses Capital sold out of Avita Medical (RCEL) in Q3 2026, closing a stake of 13,668 shares — an estimated $56.4K sold.
nVerses Capital first reported a position in RCEL in Q3 2024 and held it in 2 quarters. The position peaked at $56.4K in Q2 2026. 89 funds tracked by Wall St. Rank hold RCEL as of Q3 2026.
- nVerses Capital reported no remaining Avita Medical position as of Q3 2026 after selling out during the quarter.
- nVerses Capital sold 13,668 Avita Medical shares in Q3 2026, an estimated $56.4K.
- nVerses Capital first reported a position in Avita Medical in Q3 2024 and held it in 2 quarters.
- nVerses Capital's Avita Medical position peaked at $56.4K in Q2 2026.
- 89 funds tracked by Wall St. Rank held Avita Medical as of Q3 2026.
Based on nVerses Capital's 13F filing for Q3 2026.